tirzepatide hypothyroidism can cause and thyroid nodules: what the research actually shows about safety Tirzepatide & Thyroid Issues: Safety How Can I Take Zepbound

The goal isn't necessarily to reach the highest dose

What you do inside that window still matters

But rule out dietary and activity factors first

Clinical trial data showed that 5-6% of participants experienced hair loss at higher doses, compared to about 1% taking placebo

They are prescription medications intended for individuals who meet specific criteria, generally a BMI of 30 or greater, or a BMI of 27 or greater with a weight-related health issue like high blood pressure or high cholesterol

Add-on to metformin with or without SGLT2 inhibitor SURPASS-3 (NCT03882970) was a 52-week open-label trial that randomized 1444 adult patients with type 2 diabetes mellitus with inadequate glycemic control on stable doses of metformin with or without SGLT2 inhibitor to the addition of subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin degludec 100 units/mL once daily